Abstract
M.Com. (International Accounting)
This study assesses the compliance of South African JSE-listed companies holding biological assets with the disclosure requirements of IFRS 13, Fair Value Measurement. The financial statements of nineteen selected JSE-listed companies with material holdings of biological assets were analysed. These financial statements were for the first reporting periods beginning on or after 1 January 2015, because IFRS 13 was applicable to reporting periods from 1 January 2013 and the amendments to IAS 41 relating to bearer biological assets are applicable to reporting periods from 1 January 2016. This research therefore examines the period between when IFRS 13 first became applicable and before the IAS 41 amendments became applicable. The accounting policy notes to the financial statements of each company were analysed to determine whether they indicated that a particular company had applied IFRS 13 to the valuation of its biological assets, and the biological assets note was analysed to determine whether the valuation technique used by each company for the valuation of its biological assets complied with IFRS 13...